Current TNM classification systems for adrenocortical carcinoma;Aktuelle TNM-klassifikationssysteme für das nebennierenkarzinom

Pathologe

Volumn 31, Issue 5, 2010, Pages 374-378

  Fassnacht, M ^a   Wittekind, C ^b   Allolio, B ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Adrenocortical carcinoma; Prognosis; Resection status; Tumor staging

Indexed keywords

ADRENAL CORTEX; ADRENAL CORTEX TUMOR; ARTICLE; CANCER INVASION; CANCER STAGING; CLASSIFICATION; COHORT ANALYSIS; DISEASE COURSE; HUMAN; LYMPH NODE METASTASIS; METHODOLOGY; PATHOLOGY; PROGNOSIS; REGISTER; TUMOR EMBOLISM;

ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; COHORT STUDIES; DISEASE PROGRESSION; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; REGISTRIES;

EID: 77957583312     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-010-1306-1     Document Type: Article

References (31)

1. Abiven G, Coste J, Groussin L et al (2006) Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J Clin Endocrinol Metab 91:2650-2655
2. Assie G, Antoni G, Tissier F et al (2007) Prognostic parameters of metastatic adrenocortical carcinoma. J Clin Endocrinol Metab 92:148-154
3. Bellantone R, Ferrante A, Boscherini M et al (1997) Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. Surgery 122:1212-1218
4. Brix D, Allolio B, Fenske W et al (2010) Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients. Eur Urol [Epub ahead of print]
5. DeLellis RA, Lloyd RV, Heitz PU et al (eds) (2004) World Health Organization Classification of Tumours. Pathology and genetics of tumours of endocrine organs. IARC, Lyon, p 136
6. Edge SB, Byrd DR, Carducci MA et al American Joint Committee on Cancer (AJCC) (2009) Cancer staging manual 7th edn. Springer, New York
7. Fassnacht M, Allolio B (2009) Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab 23:273-289
8. Fassnacht M, Johanssen S, Fenske W et al (2010) Improved survival in patients with stage II adrenocortical carcinoma followed prospectively by specialized centers. J Clin Endocrinol Metab [Epub ahead of print]
9. Fassnacht M, Johanssen S, Quinkler M et al (2009) Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer 115:243-250
10. Haak HR, Hermans J, Velde CJ van de et al (1994) Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer 69:947-951
11. Hough AJ, Hollifield JW, Page DL et al (1979) Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data. Am J Clin Pathol 72:390-399
12. Icard P, Goudet P, Charpenay C et al (2001) Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg 25:891-897
13. Johanssen S, Hahner S, Saeger W et al (2010) Verbesserungsbedarf beim klinischen Management von Patienten mit Nebennierenkarzinom in Deutschland. Dtsch Ärztebl (in Druck)
14. Kebebew E, Reiff E, Duh QY et al (2006) Extent of disease at presentation and outcome for adrenocortical carcinoma: Have we made progress? World J Surg 30:872-878
15. Lee JE, Berger DH, el-Naggar AK et al (1995) Surgical management, DNA content and patient survival in adrenal cortical carcinoma. Surgery 118:1090-1098
16. Lughezzani G, Sun M, Perrotte P et al (2010) The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation. Eur J Cancer 46:713-719
17. Luton JP, Cerdas S, Billaud L et al (1990) Clinical features of adrenocortical carcinoma, prognostic factors and the effect of mitotane therapy. N Engl J Med 322:1195-1201
18. Macfarlane DA (1958) Cancer of the adrenal cortex: the natural history, prognosis and treatment in a study of fifty-five cases. Ann R C Surg Engl 23:155-186
19. Pommier RF, Brennan MF (1992) An eleven-year experience with adrenocortical carcinoma. Surgery 112:963-970; discussion 970-961
20. Schulick RD, Brennan MF (1999) Adrenocortical carcinoma. World J Urol 17:26-34
21. Sobin L, Gospodarowicz M, Wittekind C (2010) TNM classification of malignant tumours, 7th edn. Blackwell, Oxford
22. Soreide JA, Brabrand K, Thoresen SO (1992) Adrenal cortical carcinoma in Norway, 1970-1984. World J Surg 16:663-667; discussion 668
23. Sullivan M, Boileau M, Hodges CV (1978) Adrenal cortical carcinoma. J Urol 120:660-665
24. Slooten H van, Schaberg A, Smeenk D et al (1985) Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer 55:766-773
25. Vassilopoulou-Sellin R, Schultz PN (2001) Adrenocortical carcinoma. Clinical outcome at the end of the 20th century. Cancer 92:1113-1121
26. Venkatesh S, Hickey RC, Sellin RV et al (1989) Adrenal cortical carcinoma. Cancer 64:765-769
27. Wajchenberg B, Albergaria PM, Medonca B et al (2000) Adrenocortical carcinoma: clinical and laboratory observations. Cancer 88:711-736
28. Weiss LM (1984) Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8:163-169
29. Weiss LM, Medeiros LJ, Vickery AL Jr (1989) Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13:202-206
30. Wittekind C, Compton CC, Greene FL et al (2002) TNM residual tumor classification revisited. Cancer 94:2511-2516
31. Wittekind C, Greene FL, Henson DE et al (2003) UICC (2003) TNM supplement. A commentary on uniform use, 3rd edn. Wiley, New York